356 filings
8-K
DXR
Daxor Corp.
5 Jun 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
NPORT-P
DXR
Daxor Corp.
30 May 24
None (Mar 2024 report)
6:43am
4
Robert J Michel
27 Mar 24
DAXOR / Robert J Michel ownership change
1:35pm
8-K
DXR
Daxor Corp.
25 Mar 24
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
2:00pm
N-CSR/A
DXR
Daxor Corp.
19 Mar 24
Certified annual shareholder report (management investment company) (amended)
5:23pm
N-CEN
fj4ezc48vc
15 Mar 24
Annual report (registered investment company)
5:26pm
N-CSR
3ulsf8r
15 Mar 24
Certified annual shareholder report (management investment company)
4:54pm
NT-NCSR/A
727thnl2165
8 Mar 24
Notice of inability to timely file Form N-CSR (amended)
1:49pm
4
7hfl1dl1j mr9y0
6 Mar 24
DAXOR / Edward Feuer ownership change
4:18pm
NT-NCSR/A
qfek1 fb28
29 Feb 24
Notice of inability to timely file Form N-CSR (amended)
5:28pm
NT-NCSR
mkewp4rc
29 Feb 24
Notice of inability to timely file Form N-CSR
4:15pm
CORRESP
umzlxnyb of
14 Feb 24
Correspondence with SEC
12:00am
8-K
mqxi8r0ahmq
2 Jan 24
Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer
8:52am
4
juoflhh
6 Dec 23
DAXOR / Robert J Michel ownership change
3:48pm
4
29v jrcb0muk
1 Dec 23
DAXOR / Robert J Michel ownership change
9:00pm
4
3mrw779hc
1 Dec 23
DAXOR / Michael Richard Feldschuh ownership change
8:58pm
8-K
e6prm7mxh
27 Nov 23
Other Events
9:12pm
4
ebt21qy9px89nltlv 3j
27 Nov 23
DAXOR / Robert J Michel ownership change
6:03am
NPORT-P
1ljwhams41v
24 Nov 23
None (Sep 2023 report)
1:53pm
4
zpnnos77ua kln
24 Nov 23
DAXOR / Michael Richard Feldschuh ownership change
11:32am